Medicis Pharmaceutical Corp. (MRX) Reports In-Line Q2 EPS of 64c
Tweet
Share
E-mailGet Alerts MRX Hot Sheet
Price: $75.72 -1.29%
EPS Growth %: +27.1%
Financial Fact:
Income from continuing operations: 937K
Today's EPS Names:
SUNB, CULP, KFY, More
EPS Growth %: +27.1%
Financial Fact:
Income from continuing operations: 937K
Today's EPS Names:
SUNB, CULP, KFY, More
Join SI Premium – FREE
Medicis Pharmaceutical Corp. (NYSE: MRX) reported Q2 EPS of $0.64, in-line with the analyst estimate of $0.64. Revenue for the quarter came in at $190.8 million versus the consensus estimate of $188.79 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cooper Cos. (COO) Tops Q3 EPS by 3c, Offers Guidance
- United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
- Cognyte Software (CGNT) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
